MetaCap

Denali Therapeutics (DNLI) News

NASDAQ: DNLIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

18.45+0.25 (+1.37%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

DNLI news summary

We found 7 recent headlines mentioning Denali Therapeutics (DNLI): 0 in the past week and 5 in the past 30 days, most often from Nasdaq, GlobeNewswire, Investing.com. For price context, DNLI is up 1.37% at $18.45. The most recent story, "DNLI Up 7.8% Post Q3 Earnings: Should You Buy, Sell or Hold the Stock?", was published by Nasdaq on Nov 5, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Denali Therapeutics headlines

Stocks mentioned alongside DNLI

Compare DNLI